Evaluation of Changes in The Hematological Parameters, Lipid Profile and Depressive Symptoms Before and After Smoking Cessation Treatment
Evaluation of Changes in The Hematological Parameters, Lipid Profile and Depressive Symptoms Before and After Smoking Cessation Treatment
Introduction: Tobacco dependence is a cluster of behavioural, cognitive, and physiological phenomena. We aimed to investigate the changesin the hematological parameters, lipid profile and depressive symptoms before and after smoking cessation.Methods: In this intervention study, 150 cases admitted to the clinic to quit smoking and stopped smoking for at least three months were investigated.All participants have received motivational interview and appropriate medical treatment (varenicline, bupropion, nicotine replacement therapy).We designed the study to evaluate the effects of cigarette smoking on some biochemical markers and depressive symptoms.Results: Motivational interviews were conducted on all participants, and 68,7% (n = 103) were treated with varenicline, 19,3% (n=29) withbupropion and 12% (n=18) with nicotine replacement therapy (NRT). There was a statistically significant relationship between the treatmentmethod and the smoking cessation duration (p=0.002). Cessation period was longer in the group using varenicline. After quitting smoking,the Beck Depression Scores (BDS) decreased significantly (p
___
- 1. The health consequences of smoking: A report of the Surgeon
General. Atlanta. GA: Center for Disease Control and Prevention.
Office of Smoking and Health. Available from: http:/www.ncbi.nlm.
nih.gov/pubmed/20669512. Accessed 30.02.2018.
- 2. World Health Organization. WHO report on the global tobacco
epidemic 2013 [Updated 2013; cited 2014 Oct 30]. Available from:
http://www.who.int/tobacco/global_report/2013/en/ Accessed
20.01.2018.
- 3. Global adult tobacco survey, Ankara, Turkey 2012 [cited 2018 Jan 30].
Available from: http://www.who.int/tobacco/surveillance/survey/
gats/report_tur_2012.pdf?ua=1
- 4. Zevin S, Saunders S, Gourlay SG, Jacob P, Benowitz NL. Cardiovascular
effects of carbon monoxide and cigarette smoking. J Am Coll Cardiol.
2001;38:1633-8. [CrossRef]
- 5. Benowitz NL. Cigarette smoking and cardiovascular disease:
pathophysiology and implications for treatment. Prog Cardiovasc
Dis. 2003;46:91-111.
- 6. Attard R, Dingli P, Doggen CJM, Cassar K, Farrugia R, Wettinger SB. The
impact of passive and active smoking on inflammation, lipid profile
and the risk of myocardial infarction. Open Heart. 2017;4:e000620.
[CrossRef]
- 7. Steiropoulos P, Papanas N, Nena E, Xanthoudaki M, Goula T, Froudarakis
M, Pita E, Maltezos E, Bouros D. Mean platelet volume and platelet
distribution width in patients with chronic obstructivepulmonary
disease: the role of comorbidities. Angiology. 2013;64:535-9. [CrossRef]
- 8. Malenica M, Prnjavorac B, Bego T, Dujic T, Semiz S, Skrbo S, Gusic A,
Hadzic A, Causevic A. Effect of Cigarette Smoking on Haematological
Parameters in Healthy Population. Med Arch 2017;71:132-136.
[CrossRef]
- 9. Brown C, Madden PA, Palenchar DR, Cooper-Patrick L.The
association between depressive symptoms and cigarette smoking in
an urban primary care sample. Int J Psychiatry Med. 2000;30:15-26.
[CrossRef]
- 10. Balfour DJ, Ridley DL. The effects of nicotine on neural pathways
implicated in depression: a factor in nicotine addiction? Pharmacol
Biochem Behav. 2000;66:79-85. [CrossRef]
- 11. Fagerstrom KO, Heatherton TF, Kozlowski LT. Nicotine addiction and
its assessment. Ear Nose Throat J. 1990;69:763-65.
- 12. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for
measuring depression. Arch Gen Psychiatry 1961;4:561-71. [CrossRef]
- 13. Komiyama M, Shimada S, Wada H, Yamakage H, Satoh-Asahara N,
Shimatsu A, Akao M, Morimoto T, Takahashi Y, Hasegawa K. Timedependent Changes of Atherosclerotic LDL Complexes after Smoking
Cessation. J Atheroscler Thromb. 2016;23:1270-1275. [CrossRef]
- 14. Vizioli L, Muscari S, Muscari A. The relationship of mean platelet
volume with the risk and prognosis of cardiovascular diseases. Int J
Clin Pract 2009; 63:1509-15. [CrossRef]
- 15. FitzGerald GA, Oates JA, Nowak J. Cigarette smoking and hemostatic
function. Am Heart J. 1988;115(1 pt 2):267-271. [CrossRef] Hung J,
Lam JY, Lacoste L, Letchacovski G. Cigarette smoking acutely increases
platelet thrombus formation in patients with coronary artery disease
taking aspirin. Circulation. 1995;92:2432-2436 [CrossRef]
- 16. Kario K, Matsuo T, Nakao K. Cigarette smoking increases the mean
platelet volume in elderly patients with risk factors for atherosclerosis.
Clin Lab Haematol 1992;14:281–7. [CrossRef]
- 17. Takajo Y, Ikeda H, Haramaki N, Murohara T, Imaizumi T. Augmented
oxidative stress of platelets in chronic smokers. Mechanisms of
impaired platelet-derived nitric oxide bioactivity and augmented
platelet aggregability. J Am Coll Cardiol. 2001;38:1320-7. [CrossRef]
- 18. Lowe G, Rumley A, Norrie J, Ford L, Shepherd J, Cobbe S, et al. Blood
rheology, cardiovascular risk factors, and cardiovascular disease:
The West of Scotland Coronary Prevention Study; Thromb Haemost
2000;84:553-8.
- 19. Kawada T. Smoking-induced leukocytosis can persist after cessation
of smoking. Arch Med Res 2004;35:246-50. [CrossRef]
- 20. Von Eckardstein A, Nofer JR, Assmann G. High density lipoproteins
and arteriosclerosis: Role of cholesterol efflux and reverse cholesterol
transport. Arterioscler Thromb Vasc Biol 2001;21:13-27. [CrossRef]
- 21. Kutlu R, Demirbas N. The effects of smoking on platelet count, mean
platelet volume and cardiovascular risk factors: A Case-control Study.
Med Bull Haseki 2018;55:299-305. [CrossRef]
- 22. Lu P, Hu D, Lu J, Wang W, Chen B. The association between uric acid
and coronary heart disease. Zhonghua Nei Ke Za Zhi 2002;41:526-9.
- 23. Zabłocka-Słowińska K, Porębska I, Gołecki M, Kosacka M, Pawełczyk
K, Pawlik-Sobecka L, Zarębska K, Grajeta H. Contemp Oncol (Pozn).
Total antioxidant status in lung cancer is associated with levels of
endogenous antioxidants and disease stage rather than lifestyle
factors – preliminary study 2016;20:302-7. [CrossRef]
- 24. Brown C, Madden PA, Palenchar DR, Cooper-Patrick L. The
association between depressive symptoms and cigarette smoking in
an urban primary care sample. Int J Psychiatry Med 2000;30:15-26.
[CrossRef]
- 25. Devkota B, Salas J, Garfield L. Increased Risk of Major Depression With
Early Age of Exposure to Cigarettes. Am J Prev Med 2016;51:933-938.
[CrossRef]
- 26. Unsal A, Tözün, M. Relationship between smoking and depression
among adult men in a rural area in west of Turkey. TAF Prev Med Bull
2014;13:273–80. [CrossRef]
- 27. Morita H, Ikeda H, Haramaki N, Eguchi H, Imaizumi T. Only two-week
smoking cessation improves platelet aggregability and intraplatelet
redox imbalance of long-term smokers. J Am Coll Cardiol
2005;45:589-94. [CrossRef]
- 28. Marakoglu K, Cetin-Kargin N, Ucar RM, Kizmaz M. Evaluation of
pharmacologic therapies accompanied by behavioural therapy on
smoking cessation success: a prospective cohort study in Turkey.
Psychiatry and Clinical Psychopharmacology 2017;27:227–233.
[CrossRef]